Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
20,884,201
-
Shares change
-
+91,164
-
Total reported value, excl. options
-
$477,195,475
-
Value change
-
-$142,261
-
Put/Call ratio
-
268%
-
Number of buys
-
45
-
Number of sells
-
45
-
Price
-
$22.85
Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q1 2018
As of 31 Mar 2018 Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) had 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,884,201 shares of stock of the company.
Largest 10 holders included CREDIT SUISSE AG/, Birchview Capital, LP, BlackRock Inc., VANGUARD GROUP INC, CANNELL PETER B & CO INC, ArrowMark Colorado Holdings LLC, BLAIR WILLIAM & CO/IL, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., NEXT CENTURY GROWTH INVESTORS LLC, and STATE STREET CORP.
This table shows 148 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.